{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:23Z","timestamp":1790161763312,"version":"4.1.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a chronic, relapsing immune-mediated disorder of the gastrointestinal tract. Interstitial lung disease (ILD) associated with inflammatory bowel disease has been receiving increasing attention. With advances in the gut-lung axis theory, accumulating epidemiological and mechanistic evidence indicates that the association between IBD and ILD is not coincidental or merely driven by drug toxicity, but rather reflects a systemic disease spectrum involving microbiome dysbiosis and cross-organ immune dialogue. This article presents a critical narrative review that systematically summarizes the mechanisms underlying IBD-related ILD, focusing on causal evidence from large cohort and Mendelian randomization studies. It also looks at how gut microbial metabolites remotely regulate lung immune homeostasis, the inflammatory cascades triggered by gut barrier disruption and bacterial translocation, and the therapeutic potential of microbiome-based interventions. This article examines the main limitations and controversies, including the limited accuracy of animal models, the unclear causal link between microbial changes and disease onset, and the challenges in selecting clinical trial endpoints. It also outlines future research directions, focusing on integrating multi-omics, non-invasive diagnostic models, and strategies to distinguish drug-induced lung injury from primary disease involvement. This review aims to elucidate the pathogenesis of this cross-organ disease spectrum and to provide a theoretical foundation for both basic research and clinical translation.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1967125","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:15:06Z","timestamp":1790158506000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiome-driven mechanisms in inflammatory bowel disease-associated interstitial lung disease: from dysbiosis to therapeutic implications"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanli","family":"Yang","sequence":"first","affiliation":[{"name":"Respiratory Department, First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Respiratory Department, First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Liu","sequence":"additional","affiliation":[{"name":"Respiratory Department, First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","article-title":"Multiomics to elucidate inflammatory bowel disease risk factors and pathways","volume":"19","author":"Agrawal","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0000000000002327","article-title":"Increased\u00a0prevalence of pulmonary diseases in patients with inflammatory bowel disease:\u00a0a\u00a0retrospective multicenter study","author":"Ailawadi","year":"2026","journal-title":"J. Clin. Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/acr.25623","article-title":"International investigation of the gut-lung axis in systemic sclerosis-interstitial lung disease","volume":"78","author":"Andr\u00e9asson","year":"2026","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00677-23","article-title":"Poly-omic risk scores predict inflammatory bowel disease diagnosis","volume":"9","author":"Arehart","year":"2024","journal-title":"mSystems"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110231","article-title":"Short chain fatty acids: fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases","volume":"368","author":"Ashique","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjag096","article-title":"Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort study","volume":"20","author":"Baekdal","year":"2026","journal-title":"J. Crohns Colitis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1761248","article-title":"Formononetin: a promising therapeutic agent targeting the gut-lung axis in acute lung injury","volume":"17","author":"Batu","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/biom16060833","article-title":"The gut-lung microbiome crosstalk and pulmonary disease","volume":"16","author":"Beyo\u011flu","year":"2026","journal-title":"Biomolecules"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6298662","article-title":"Protective effect of dietary polysaccharides from yellow passion fruit peel on DSS-induced colitis in mice","volume":"2022","author":"Bueno","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut-lung axis","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00408-022-00581-8","article-title":"Gut-lung microbiota interactions in chronic obstructive pulmonary disease (COPD): potential mechanisms driving progression to COPD and epidemiological data","volume":"200","author":"De Nuccio","year":"2022","journal-title":"Lung"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1726732","article-title":"Association between OLD and IBD: a systematic review and meta-analysis","volume":"17","author":"Ding","year":"2026","journal-title":"Front. Immunol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13111005","article-title":"The intriguing connection between the gut and lung microbiomes","volume":"13","author":"Druszczynska","year":"2024","journal-title":"Pathogens"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0344511","article-title":"STING pathway contributes to steroid-hyporesponsive lung inflammation in DSS-induced colitis mice model","volume":"21","author":"Eladham","year":"2026","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0324230","article-title":"The role of gut leakage and immune cell miss-homing on gut dysbiosis-induced lung inflammation in a DSS mice model","volume":"20","author":"Eladham","year":"2025","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/mpg.0000000000001989","article-title":"Pulmonary function tests abnormalities in children with inflammatory bowel disease: is it common","volume":"67","author":"El Amrousy","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.933774","article-title":"Risks of SARS-CoV-2 infection and immune response to COVID-19 vaccines in patients with inflammatory bowel disease: current evidence","volume":"13","author":"Esposito","year":"2022","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.70064","article-title":"Advances in biosensors for diagnosis and monitoring of inflammatory bowel disease: a review","volume":"10","author":"Fu","year":"2025","journal-title":"Bioeng. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118616","article-title":"Pulmonary fibrosis alters gut microbiota and associated metabolites in mice: an integrated 16S and metabolomics analysis","volume":"264","author":"Gong","year":"2021","journal-title":"Life Sci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.99282","article-title":"Intestinal microbiome dysbiosis increases Mycobacteria pulmonary colonization in mice by regulating the Nos2-associated pathways","volume":"13","author":"Han","year":"2024","journal-title":"Elife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/1040841x.2016.1176988","article-title":"Gut-lung axis: the microbial contributions and clinical implications","volume":"43","author":"He","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"28743","DOI":"10.1038\/s41598-024-80023-y","article-title":"Triangle correlations of lung microbiome, host physiology and gut microbiome in a rat model of idiopathic pulmonary fibrosis","volume":"14","author":"Hou","year":"2024","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.153514","article-title":"Torreya grandis polysaccharide alleviates acute lung injury via the lung-gut axis: gut microbiota and immune regulation mechanisms","volume":"375","author":"Hu","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1730289","article-title":"Multi-omics integration and machine learning reveal gut-immune signatures in idiopathic pulmonary fibrosis: insights from bulk RNA-seq, single-cell profiles, spatial transcriptomics, and experimental validation","volume":"17","author":"Hu","year":"2026","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155997","article-title":"Xuanfei Baidu decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFN\u03b3\/STAT1\/STAT3 axis","volume":"135","author":"Jia","year":"2024","journal-title":"Phytomedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.14309\/ajg.0000000000003699","article-title":"Patients with inflammatory bowel disease are at increased risk of interstitial lung diseases","volume":"121","author":"Kochar","year":"2026","journal-title":"Am. J. Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12864-020-6652-7","article-title":"Deep in the bowel: Highly interpretable neural encoder-decoder networks predict gut metabolites from gut microbiome","volume":"21","author":"Le","year":"2020","journal-title":"BMC Genomics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjag022","article-title":"Epigenetic biomarkers in inflammatory bowel diseases\u2014computational challenges and opportunities","volume":"20","author":"Lee","year":"2026","journal-title":"J. Crohns Colitis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5009\/gnl250360","article-title":"Translating gut microbiota into diagnostics: a multidimensional approach for the diagnosis of inflammatory bowel disease","volume":"20","author":"Lee","year":"2026","journal-title":"Gut Liver"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cells13080675","article-title":"Inhibition of immunoproteasome attenuates NLRP3 inflammasome response by regulating E3 ubiquitin ligase TRIM31","volume":"13","author":"Lee","year":"2024","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41467-022-35767-4","article-title":"Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection","volume":"14","author":"Le Guern","year":"2023","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12931-026-03752-w","article-title":"The gut-lung axis in ARDS: beyond microbial translocation","volume":"27","author":"Li","year":"2026","journal-title":"Respir. Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00430-25","article-title":"Gut microbiota impact on lung diseases: a mini review of clinical evidence","volume":"94","author":"Liu","year":"2026","journal-title":"Infect. Immun."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1796944","article-title":"The gut-lung axis: pathological crosstalk and inter-organ communication in chronic obstructive pulmonary disease and inflammatory bowel disease","volume":"17","author":"Liu","year":"2026","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1296889","article-title":"Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.hrtlng.2023.05.016","article-title":"The gut-lung axis: Mendelian randomization identifies a causal association between inflammatory bowel disease and interstitial lung disease","volume":"61","author":"Luo","year":"2023","journal-title":"Heart Lung"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1021\/acs.est.5c00798","article-title":"Microbial dysbiosis in the lung and gut in response to inhalable particulate matters in pneumoconiosis patients and animals","volume":"59","author":"Ma","year":"2025","journal-title":"Environ. Sci. Technol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818769076","article-title":"Emerging concepts in non-invasive monitoring of Crohn's disease","volume":"11","author":"Marlicz","year":"2018","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00108-018-0473-7","article-title":"Lungenbeteiligung bei chronisch-entz\u00fcndlichen Darmerkrankungen [Aspects of pulmonary involvement in inflammatory bowel disease]","volume":"59","author":"Moeser","year":"2018","journal-title":"Internist (Berl)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1883855","article-title":"Pulmonary injury in inflammatory bowel disease: intestinal barrier disruption, gut-lung axis remodeling, and treatment-related lung toxicity","volume":"17","author":"Mu","year":"2026","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","article-title":"Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts","volume":"14","author":"Ning","year":"2023","journal-title":"Nat. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40257-022-00689-w","article-title":"Cutaneous manifestations of inflammatory bowel disease: a basic overview","volume":"23","author":"Pagani","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/crocol\/otag085","article-title":"Confirming the association of ulcerative colitis with interstitial lung disease: a retrospective analysis of comorbid disease, demographics, and healthcare utilization","volume":"8","author":"Parekh","year":"2026","journal-title":"Crohns Colitis 360"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01990-23","article-title":"Gut microbial dysbiosis occurring during pulmonary fungal infection in rats is linked to inflammation and depends on healthy microbiota composition","volume":"11","author":"Popovic","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1738689","article-title":"Microbiome in connective tissue diseases associated interstitial lung disease","volume":"13","author":"Puppo","year":"2026","journal-title":"Front. Med. (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309921","article-title":"Stable biomarker discovery in multi-omics data via canonical correlation analysis","volume":"19","author":"Pusa","year":"2024","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1125260","article-title":"Development of severe colitis is associated with lung inflammation and pathology","volume":"14","author":"Raftery","year":"2023","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155699","article-title":"The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis","volume":"129","author":"Ruan","year":"2024","journal-title":"Phytomedicine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2154092","article-title":"Stool multi-omics for the study of host-microbe interactions in inflammatory bowel disease","volume":"14","author":"Sauceda","year":"2022","journal-title":"Gut Microbes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115150","article-title":"Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: a review","volume":"165","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.51821\/86.2.7758","article-title":"Respiratory involvement in Crohn's disease: a case report","volume":"86","author":"Taelman","year":"2023","journal-title":"Acta Gastroenterol. Belg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-981-15-2385-4_5","article-title":"Gut microbiota and lung injury","volume":"1238","author":"Tan","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27185838","article-title":"A comprehensive analysis of microflora and metabolites in the development of ulcerative colitis into colorectal cancer based on the lung-gut correlation theory","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxag138","article-title":"Potential roles of gut microbiome and metabolomes in interstitial lung disease: evidence across preclinical and clinical research","volume":"137","author":"Thonghem","year":"2026","journal-title":"J. Appl. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000720","article-title":"Interstitial lung disease as an emerging contributor to mortality in patients with inflammatory bowel disease: a population-based epidemiological study","volume":"15","author":"Vaezi","year":"2024","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1183\/13993003.congress-2022.1785","article-title":"Prevalence of and factors associated with respiratory symptoms among patients with inflammatory bowel disease: a prospective study","volume":"29","author":"Valentin","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1021\/acsomega.3c05846","article-title":"Short-chain fatty acid (SCFA) as a connecting link between microbiota and gut-lung axis-a potential therapeutic intervention to improve lung health","volume":"9","author":"Verma","year":"2024","journal-title":"ACS Omega"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27104213","article-title":"Characteristics of gut microbiota in patients with chronic obstructive pulmonary disease based on metagenomics and metabolomics","volume":"27","author":"Wang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.943791","article-title":"Gut microbiome and metabolites: the potential key roles in pulmonary fibrosis","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1817835","article-title":"Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis","volume":"13","author":"Wu","year":"2026","journal-title":"Front. Med. (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molimm.2025.05.024","article-title":"Gut microbiota-derived proline-leucine dipeptide aggravated sepsis-induced acute lung injury via activating Nod2\/NF-\u03baB signaling pathway","volume":"184","author":"Yang","year":"2025","journal-title":"Mol. Immunol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1711299","article-title":"Lung-gut axis, intestinal microbiota, and pulmonary fibrosis: mechanisms and therapeutic potential","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"45351","DOI":"10.1038\/s41598-025-29758-w","article-title":"Triptolide ameliorates LPS-induced acute lung injury in Balb\/c mice through gut-lung axis-mediated regulation of bile acid metabolism and gut microbiota","volume":"15","author":"Zha","year":"2025","journal-title":"Sci. Rep."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00301","article-title":"The cross-talk between gut microbiota and lungs in common lung diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1346923","article-title":"Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Nutr."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006808","article-title":"Pulmonary dysfunction in 114 patients with inflammatory bowel disease","volume":"96","author":"Zhao","year":"2017","journal-title":"Med. (Baltimore)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1241262","article-title":"Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity","volume":"14","author":"Zhong","year":"2023","journal-title":"Front. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13054-024-05006-x","article-title":"Gut-derived immune cells and the gut-lung axis in ARDS","volume":"28","author":"Ziaka","year":"2024","journal-title":"Crit. Care"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1967125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:15:07Z","timestamp":1790158507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1967125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":68,"alternative-id":["10.3389\/fcimb.2026.1967125"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1967125","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1967125"}}